Disentangling the genetic overlap between cholesterol and suicide risk

Abstract

Suicide is major public health concern; one million individuals worldwide die by suicide each year of which there are many more attempts. Thus, it is imperative that robust and reliable indicators, or biomarkers, of suicide risk be identified so that individuals at risk can be identified and provided appropriate interventions as quickly as possible. Previous work has revealed a relationship between low levels of circulating cholesterol and suicide risk, implicating cholesterol level as one such potential biomarker, but the factors underlying this relationship remain unknown. In the present study, we applied a combination of bivariate polygenic and coefficient-of-relatedness analysis, followed by mediation analysis, in a large sample of Mexican-American individuals from extended pedigrees [N = 1897; 96 pedigrees (average size = 19.17 individuals, range = 2–189) 60% female; mean age = 42.58 years, range = 18–97 years, sd = 15.75 years] with no exclusion criteria for any given psychiatric disorder. We observed that total esterified cholesterol measured at the time of psychiatric assessment shared a significant genetic overlap with risk for suicide attempt (ρg = −0.64, p = 1.24 × 10−04). We also found that total unesterified cholesterol measured around 20 years prior to assessment varied as a function of genetic proximity to an affected individual (h2 = 0.21, se = 0.10, p = 8.73 × 10−04; βsuicide = −0.70, se = 0.25, p = 8.90 × 10−03). Finally, we found that the relationship between total unesterified cholesterol and suicide risk was significantly mediated by ABCA-1-specific cholesterol efflux capacity (βsuicide-efflux = −0.45, p = 0.039; βefflux-cholexterol = −0.34, p < 0.0001; βindirect = −0.15, p = 0.044). These findings suggest that the relatively well-delineated process of cholesterol metabolism and associated molecular pathways will be informative for understanding the neurobiological underpinnings of risk for suicide attempt.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. Br Med J. 1990;301:309–14.

  2. 2.

    Cantarelli Mda G, Tramontina AC, Leite MC, Goncalves CA. Potential neurochemical links between cholesterol and suicidal behavior. Psychiatry Res. 2014;220:745–51.

  3. 3.

    Nock MK, Borges G, Bromet EJ, Cha CB, Kessler RC, Lee S. Suicide and suicidal behavior. Epidemiol Rev. 2008;30:133–54.

  4. 4.

    World Health Organization. SuicideData. 2017. http://www.who.int/mental_health/prevention/suicide/suicideprevent/en/. Accessed 18 Jan 2018.

  5. 5.

    Pandey GN, Dwivedi Y. Peripheral biomarkers for suicide. In: Dwivedi Y, editor. The neurobiological basis of suicide. Boca Raton, FL: CRC Press/Taylor Francis; 2012.

  6. 6.

    Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS. 2010;5:463–6.

  7. 7.

    Niculescu AB, Levey DF, Phalen PL, Le-Niculescu H, Dainton HD, Jain N, et al. Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach. Mol Psychiatry. 2015;20:1266–85.

  8. 8.

    Franklin JC, Ribeiro JD, Fox KR, Bentley KH, Kleiman EM, Huang X, et al. Risk factors for suicidal thoughts and behaviors: a meta-analysis of 50 years of research. Psychol Bull. 2017;143:187–232.

  9. 9.

    Wu S, Ding Y, Wu F, Xie G, Hou J, Mao P. Serum lipid levels and suicidality: a meta-analysis of 65 epidemiological studies. J Psychiatry Neurosci. 2016;41:56–69.

  10. 10.

    Feingold KR, Grunfeld C. Introduction to lipids and lipoproteins. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM et al., editors. Endotext. South Dartmouth, MA: MDText.com, Inc.; 2000.

  11. 11.

    Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res. 2005;96:1221–32.

  12. 12.

    Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR, Wedin KE, et al. HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med. 2014;371:2383–93.

  13. 13.

    Cornier MA, Despres JP, Davis N, Grossniklaus DA, Klein S, Lamarche B, et al. Assessing adiposity: a scientific statement from the American Heart Association. Circulation. 2011;124:1996–2019.

  14. 14.

    Mitchell BD, Kammerer CM, Blangero J, Mahaney MC, Rainwater DL, Dyke B, et al. Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. Circulation. 1996;94:2159–70.

  15. 15.

    Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22–33.

  16. 16.

    Knowles EEM, Huynh K, Meikle PJ, Göring HHH, Olvera RL, Mathias SR, et al. The lipidome in major depressive disorder: shared genetic influence for ether-phosphatidylcholines, a plasma-based phenotype related to inflammation, and disease risk. Eur Psychiatry. 2017;43:44–50.

  17. 17.

    Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62:1198–211.

  18. 18.

    Glahn DC, Curran JE, Winkler AM, Carless MA, Kent JW Jr, et al. High dimensional endophenotype ranking in the search for major depression risk genes. Biol Psychiatry. 2012;71:6–14.

  19. 19.

    Glahn DC, Williams JT, McKay DR, Knowles EE, Sprooten E, Mathias SR, et al. Discovering schizophrenia endophenotypes in randomly ascertained pedigrees. Biol Psychiatry. 2015;77:75–83.

  20. 20.

    Knowles EEM, Meikle PJ, Huynh K, Göring HHH, Olvera RL, Mathias SR, et al. Serum phosphatidylinositol as a biomarker for bipolar disorder liability. Bipolar Disord. 2017;19:107–15.

  21. 21.

    Muthén LK, Muthén BO. Mplus user’s guide. 6th ed. Los Angeles, CA: Muthén & Muthén; 2011.

  22. 22.

    Rice TK, Sung YJ, Shi G, Gu CC, Rao D. Genome-wide association analysis of Framingham Heart Study data for the Genetics Analysis Workshop 16: effects due to medication use. BMC Proc. 2009;3:S52.

  23. 23.

    Rader DJ, Alexander ET, Weibel GL, Billheimer J, Rothblat GH. The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J Lipid Res. 2009;50:S189–94.

  24. 24.

    Engelberg H. Low serum cholesterol and suicide. Lancet. 1992;339:727–9.

  25. 25.

    Paaver M, Nordquist N, Parik J, Harro M, Oreland L, Harro J. Platelet MAO activity and the 5-HTT gene promoter polymorphism are associated with impulsivity and cognitive style in visual information processing. Psychopharmacology. 2007;194:545–54.

  26. 26.

    Barratt E. Impulsiveness and aggression. Chicago: University of Chicago; 1994. pp. 61–79.

  27. 27.

    Barratt ES, Stanford MS, Dowdy L, Liebman MJ, Kent TA. Impulsive and premeditated aggression: a factor analysis of self-reported acts. Psychiatry Res. 1999;86:163–73.

  28. 28.

    Corruble E, Damy C, Guelfi JD. Impulsivity: a relevant dimension in depression regarding suicide attempts? J Affect Disord. 1999;53:211–5.

  29. 29.

    Lester D. Serum cholesterol levels and suicide: a meta-analysis. Suicide Life Threat Behav. 2002;32:333–46.

  30. 30.

    Alvarez JC, Cremniter D, Lesieur P, Gregoire A, Gilton A, Macquin-Mavier I, et al. Low blood cholesterol and low platelet serotonin levels in violent suicide attempters. Biol Psychiatry. 1999;45:1066–9.

  31. 31.

    Chamberlain SR, Sahakian BJ. The neuropsychiatry of impulsivity. Curr Opin Psychiatry. 2007;20:255–61.

  32. 32.

    Sudol K, Mann JJ. Biomarkers of suicide attempt behavior: towards a biological model of risk. Curr Psychiatry Rep. 2017;19:31.

  33. 33.

    Sarchiapone M, Camardese G, Roy A, Della Casa S, Satta MA, Gonzalez B, et al. Cholesterol and serotonin indices in depressed and suicidal patients. J Affect Disord. 2001;62:217–9.

  34. 34.

    Atmaca M, Kuloglu M, Tezcan E, Ustundag B, Gecici O, Firidin B. Serum leptin and cholesterol values in suicide attempters. Neuropsychobiology. 2002;45:124–7.

  35. 35.

    Atmaca M, Kuloglu M, Tezcan E, Ustundag B. Serum leptin and cholesterol values in violent and non-violent suicide attempters. Psychiatry Res. 2008;158:87–91.

  36. 36.

    Sullivan PF, Joyce PR, Bulik CM, Mulder RT, Oakley-Browne M. Total cholesterol and suicidality in depression. Biol Psychiatry. 1994;36:472–7.

  37. 37.

    Golier JA, Marzuk PM, Leon AC, Weiner C, Tardiff K. Low serum cholesterol level and attempted suicide. Am J Psychiatry. 1995;152:419–23.

  38. 38.

    Kunugi H, Takei N, Aoki H, Nanko S. Low serum cholesterol in suicide attempters. Biol Psychiatry. 1997;41:196–200.

  39. 39.

    Seneviratne SL, Warnasooriya WM, Gunatilake SB, Fonseka MM, Gunawardena MK, de Silva HJ. Serum cholesterol concentrations in parasuicide. Ceylon Med J. 1999;44:11–3.

  40. 40.

    Partonen T, Haukka J, Virtamo J, Taylor PR, Lonnqvist J. Association of low serum total cholesterol with major depression and suicide. Br J Psychiatry. 1999;175:259–62.

  41. 41.

    Kunugi H, Takei N, Aoki H, Nanko S. Low serum cholesterol in suicide attempters. Biol Psychiatry. 1997;41:196–200.

  42. 42.

    Turecki G. The molecular bases of the suicidal brain. Nat Rev Neurosci. 2014;15:802–16.

  43. 43.

    Willour VL, Seifuddin F, Mahon PB, Jancic D, Pirooznia M, Steele J, et al. A genome-wide association study of attempted suicide. Mol Psychiatry. 2012;17:433–44.

  44. 44.

    Pawlak J, Dmitrzak-Weglarz M, Wilkosc M, Szczepankiewicz A, Leszczynska-Rodziewicz A, Zaremba D, et al. Suicide behavior as a quantitative trait and its genetic background. J Affect Disord. 2016;206:241–50.

  45. 45.

    Stanford SM, Bottini M, Bottini N. The role of LMPTP in the metabolic syndrome. In: Bence KK, editor. Protein tyrosine phosphatase control of metabolism. New York, NY, Heidelberg, Dordrecht, London: Springer; 2013. pp. 203–20.

  46. 46.

    Gibbons RD, Kupfer D, Frank E, Moore T, Beiser DG, Boudreaux ED. Development of a computerized adaptive test suicide scale—the CAT-SS. J Clin Psychiatry. 2017;78:1376–82.

  47. 47.

    Niculescu AB, Le-Niculescu H, Levey DF, Phalen PL, Dainton HL, Roseberry K, et al. Precision medicine for suicidality: from universality to subtypes and personalization. Mol Psychiatry. 2017;22:1250–73.

  48. 48.

    Niculescu AB, Levey DF, Phalen PL, Le-Niculescu H, Dainton HD, Jain N, et al. Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach. Mol Psychiatry. 2015;20:1266–85.

  49. 49.

    Perera S, Eisen RB, Bhatt M, Dennis BB, Bawor M, El-Sheikh W, et al. Exploring metabolic factors and health behaviors in relation to suicide attempts: a case-control study. J Affect Disord. 2018;229:386–95.

  50. 50.

    Tucker KL. Assessment of usual dietary intake in population studies of gene-diet interaction. Nutr Metab Cardiovasc Dis. 2007;17:74–81.

  51. 51.

    Prentice RL. Dietary assessment and the reliability of nutritional epidemiology research reports. J Natl Cancer Inst. 2010;102:583–5.

  52. 52.

    Briefel RR, Sempos CT, McDowell MA, Chien S, Alaimo K. Dietary methods research in the third National Health and Nutrition Examination Survey: underreporting of energy intake. Am J Clin Nutr. 1997;65:1203S–9S.

  53. 53.

    Docherty AR, Kremen WS, Panizzon MS, Prom-Wormley EC, Franz CE, Lyons MJ, et al. Comparison of twin and extended pedigree designs for obtaining heritability estimates. Behav Genet. 2015;45:461–6.

  54. 54.

    Sorenson SB, Golding JM. Prevalence of suicide attempts in a Mexican-American population: prevention implications of immigration and cultural issues. Suicide Life Threat Behav. 1988;18:322–33.

  55. 55.

    Olvera RL. Suicidal ideation in Hispanic and mixed-ancestry adolescents. Suicide Life Threat Behav. 2001;31:416–27.

  56. 56.

    Fortuna LR, Perez DJ, Canino G, Sribney W, Alegria M. Prevalence and correlates of lifetime suicidal ideation and suicide attempts among Latino subgroups in the United States. J Clin Psychiatry. 2007;68:572–81.

  57. 57.

    Borges G, Breslau J, Su M, Miller M, Medina-Mora ME, Aguilar-Gaxiola S. Immigration and suicidal behavior among Mexicans and Mexican Americans. Am J Public Health. 2009;99:728–33.

  58. 58.

    Rodriguez CJ, Cai J, Swett K, Gonzalez HM, Talavera GA, Wruck LM et al. High cholesterol awareness, treatment, and control among Hispanic/Latinos: results from the Hispanic Community Health Study/Study of Latinos. J Am Heart Assoc. 2015;4. https://doi.org/10.1161/JAHA.115.001867.

  59. 59.

    Hughes TM, Rosano C, Evans RW, Kuller LH. Brain cholesterol metabolism, oxysterols, and dementia. J Alzheimers Dis. 2013;33:891–911.

Download references

Funding

Grant sponsor: National Institute of Mental Health; Grant numbers: MH078143, MH078111, MH083824; Grant sponsor: SOLAR NIMH; Grant number: MH059490.

Author information

Correspondence to Emma E. M. Knowles.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Table S1

Supplemental Methods

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Further reading